CLK1-IN-5
CLK1-IN-5 is a potent and selective CLK1 inhibitor with an IC50 of 23 nM. CLK1-IN-5 can be used in the research of cancer and Alzheimer's disease.
For research use only. We do not sell to patients.
- Formula: C13H14N4OS
- Molecular Weight:274.34
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
CLK1-IN-5 (Compound 2) potently inhibits purified mouse CLK1 protein, with an IC50 of 23 nM and a ligand efficiency of 0.56[1].
CLK1-IN-5 (2 h) binds to ectopically expressed CLK1, DYRK1A, and DYRK2 in HEK293T cells, with EC50 values of 3443, 8414, and > 10000 nM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 274.34
-
Formula C13H14N4OS
-
SMILES
CCCNC1=NN2C(S1)=NC=C2C3=CC=C(O)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)